[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100109104":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":22,"locations":27,"responsibleParty":44,"collaborators":10,"id":46,"slug":10,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":47,"sex":51,"minAge":10,"maxAge":10,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"St. Jude Children's Research Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational Group",null,"Data Collection",[13],"Other: Data Collection",[15],{"type":6,"name":11,"description":16,"armGroupLabels":17,"otherNames":10},"Continuing review of outcomes and late toxicities",[9],[19],{"name":20,"affiliation":5,"role":21},"Melissa M Hudson, MD","PRINCIPAL_INVESTIGATOR",[23],{"name":20,"role":24,"phone":25,"phoneExt":10,"email":26},"CONTACT","888-226-4343","referralinfo@stjude.org",[28],{"facility":5,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"RECRUITING","Memphis","Tennessee","38105","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-90.04898,35.14953,{"lat":39,"lon":38},[42,43],{"name":20,"role":24,"phone":25,"phoneExt":10,"email":26},{"name":20,"role":21,"phone":10,"phoneExt":10,"email":10},{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100109104",false,"NCT00684580","Protocol For Collecting Data On Patients With Childhood Cancer","Inclusion Criteria:\n\n* All St Jude patients actively being followed or treated for childhood cancer\n\nExclusion Criteria:\n\n* St. Jude consult only patients\n* St. Jude patients permanently discharged from care and follow-up Permanently discharged patients include patients who have electively transferred their oncologic care to another institution, those who are noncompliant with recommended follow-up or those leaving the institution against medical advice.\n* Patients referred to St. Jude for limited care on phase 1 protocol.","ALL",{"count":53,"type":54},30000,"ESTIMATED","OBSERVATIONAL","Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.",[58],"Childhood Cancer",[60,61],"St. Jude Alumni","St. Jude Life Participants","2026-06-15",{"date":64,"type":65},"2026-06-17","ACTUAL",{"date":67,"type":65},"2000-06-08",{"date":69,"type":54},"2045-05",{"name":5,"class":6},1]